15.56USD-4.66%Mkt Cap: 1.21B USDP/E: —Last update: 2026-06-01
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operate…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap1.21B USD
Enterprise Value3.02B USD
Revenue (TTM)1.64B USD
Gross Profit831.62M USD
Net Income (TTM)-516.47M USD
Revenue/Share21.41 USD
Last Price15.56 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4.4K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS4579852082
Valuation
P/E (Trailing)—
P/E (Forward)6.14
PEG0.67
EV/EBITDA9.81
EV/Revenue1.84
P/S0.76
P/B1.20
EPS (TTM)-6.47
EPS (Forward)2.61
52W Range
8.70086% of range16.70
52W High16.70 USD
52W Low8.700 USD
Profitability
Gross Margin50.86%
Oper. Margin10.41%
EBITDA Margin18.75%
Profit Margin-31.58%
ROE-49.50%
ROA-14.34%
Growth
Revenue Growth2.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF50.38M USD
CapEx (TTM)95.64M USD
FCF Margin4.21%
FCF Yield5.73%
Net Debt1.78B USD
Net Debt/EBITDA5.76
Balance Sheet
Debt/Equity1.95
Current Ratio3.38
Quick Ratio1.53
Book Value/Sh13.39 USD
Cash/Share3.413 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateJan 4, 2017
Analyst Consensus
Rating2.9 (Hold)
Target (Mean)17.43 USD
Target Range11.00 USD – 27.00 USD
# Analysts7
Ownership
Shares Out.77.80M
Float58.69M
Insiders14.41%
Institutions101.08%
Short Interest
Short Ratio8.1d
Short % Float16.31%
Short % Out.11.83%
Shares Short9.20M
Short (prev mo.)9.16M
Technical
SMA 5011.55 (+34.7%)
SMA 20012.58 (+23.7%)
Beta1.08
S&P 52W Chg27.94%
Avg Vol (30d)1.01M
Avg Vol (10d)961.91K
Technical Indicators
RSI (14)74.0
MACD1.2245
MACD Signal1.1246
MACD Hist.+0.0999
BB Upper17.12 USD
BB Middle14.23 USD
BB Lower11.34 USD
BB Width40.63%
ATR (14)0.8260 USD
Vol Ratio (20d)0.29x